Sharda Cropchem Limited
National Stock Exchange of IndiaTotal Valuation
Sharda Cropchem Limited carries a market capitalization of 83.09B, placing it among publicly traded companies globally. Its enterprise value stands at 73.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 83.09B |
| Enterprise Value | 73.20B |
Valuation Ratios
Sharda Cropchem Limited trades at a trailing price-to-earnings ratio of 17.43.
| PE Ratio | 17.43 |
| PS Ratio | 1.62 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Sharda Cropchem Limited trades at an EV/EBITDA multiple of 14.07 and an EV/FCF ratio of 4,743.56. The EV/Sales ratio of 1.62 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.07 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.62 |
| EV / EBITDA | 14.07 |
| EV / EBIT | 14.07 |
| EV / FCF | 4,743.56 |
Financial Position
Sharda Cropchem Limited maintains a current ratio of 3.95, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.84, indicating moderate leverage, while an interest coverage ratio of 273.95 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.95 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | N/A |
| Interest Coverage | 273.95 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 217.76 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Sharda Cropchem Limited has paid 967.28M in income taxes, reflecting an effective tax rate of 18.72.
| Income Tax | 967.28M |
| Effective Tax Rate | 18.72 |
Stock Price Statistics
Sharda Cropchem Limited's stock has gained approximately 7.90275% over the past 52 weeks. The 50-day moving average sits at 963.06, while the 200-day moving average is 940.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.90275% |
| 50-Day Moving Average | 963.06 |
| 200-Day Moving Average | 940.90 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Sharda Cropchem Limited generated 45.20B in revenue and converted that into 4.20B in net income, yielding earnings per share of 46.55. EBITDA reached 5.20B, while operating income came in at 5.20B.
| Revenue | 45.20B |
| Gross Profit | 14.12B |
| Operating Income | 5.20B |
| Pretax Income | 5.17B |
| Net Income | 4.20B |
| EBITDA | 5.20B |
| EBIT | 5.20B |
| Earnings Per Share (EPS) | 46.55 |
Margins
Sharda Cropchem Limited operates with a gross margin of 31.24, reflecting its pricing power and cost economics. The operating margin of 11.51 and net profit margin of 9.29 provide insight into operational efficiency.
| Gross Margin | 31.24 |
| Operating Margin | 11.51 |
| Pretax Margin | 11.43 |
| Profit Margin | 9.29 |
| EBITDA Margin | 11.51 |
Scores
Sharda Cropchem Limited posts an Altman Z-Score of 8.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.55 |